Surveillance report updates characteristics of U.S. patients with vaping-associated lung injury

This observational surveillance report from the United States describes characteristics of patients with lung injury related to e-cigarette or vaping product use. The report provides updated data on patient demographics and substances found in vaping products as of October 15, 2019, though specific sample sizes, absolute numbers, and statistical measures were not reported. No comparator group was specified, and the analysis focuses on descriptive characteristics rather than causal inference.

No safety or tolerability data were reported in this surveillance update. The report does not include information on adverse events, serious adverse events, or treatment discontinuations related to the lung injuries.

Key limitations include the observational nature of the data, which can only show association rather than causation. The report does not provide specific sample sizes, statistical analyses, or follow-up information. Funding sources and potential conflicts of interest were not reported.

For clinical practice, this surveillance report provides descriptive information about a national outbreak of vaping-associated lung injuries. The data may help clinicians recognize patterns in affected populations but should not be interpreted as establishing causal relationships between specific products and lung injury outcomes.